Categories
- About MIMS Ireland
- New Products
- New Presentations
- New this Month
- Discontinued Products
- New Clinical Evidence
- Clinical Specials
- Irish Medicines Board
- Medicines and Sport
Archives
- December 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
Tagcloud
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome
MIMS Ireland: May 2009
Tibolone and Breast Cancer: Results of the LIBERATE trial
01 May 2009 | Irish Medicines Board
Tibolone (Livial) is a synthetic hormone therapy that is licensed as a first-line treatment for menopausal symptoms and a second-line therapy for prevention of osteoporosis in postmenopausal women who are at high risk of future fracture.... Read more
Avastin in advanced breast cancer - RIBBON-1
01 May 2009 | New Clinical Evidence
New phase III study of Avastin in advanced breast cancer meets its primary endpoint of increasing Progression Free Survival.... Read more
Results from TEAM trial with Aromasin
01 May 2009 | New Clinical Evidence
Pfizer wish to announce results from a first planned analysis of the TEAM (Tamoxifen, Exemestane, Adjuvant, Multicentre) trial conducted in postmenopausal women with hormone sensitive early breast cancer.... Read more
Bicalutamide Teva
01 May 2009 | New Products
Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. HT. Sport permitted. Active ingredient: Bicalutamide 50mg. Description: White to off-white biconvex, film-coated tablet, debossed with 93 on one side and 220 on the other. Indications: Advanced prostatic carcinoma in combination with luteinising... Read more
Dozept
01 May 2009 | New Products
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Donepezil HCl 5mg, 10mg. Description: Respectively, white (diameter 7mm) or yellow (diameter 9mm) film-coated tablets. 10mg tablets have a score line and can be divided into equal halves. Presentation:... Read more
Fostolin
01 May 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Alendronic acid 70mg. Description: Round, white, biconvex tablets marked 70 on one side. Presentation: Available on request Indications: Postmenopausal osteoporosis. Alendronic acid reduces the risk of vertebral and... Read more
Klaram
01 May 2009 | New Products
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Clarithromycin 250mg, 500mg. Description: Yellow, oval, biconvex film-coated tablets marked with 250 and 500 respectively on one side and CL on the other side. Presentation: Prices available on... Read more
Ratiograstim
01 May 2009 | New Products
Company: Ratiopharm direct. Legal category: Prescription. HT. Sport prohibited. Active ingredient: Filgrastim 60MIU/ml. Description: Clear, colourless solution for injection or infusion in pre-filled syringes. Presentation: 30 MIU/0.5ml-5, €448.37; 48MIU/0.8 ml-5, € 714.96. Indications: Reduction in duration of neutropenia and incidence... Read more
RoActemra
01 May 2009 | New Products
Company: Roche Products (Ireland) Ltd. Legal category: Hospital only. Sport pending. Active ingredient: Tocilizumab 20mg/ml. Description: Concentrate for solution for infusion in vials. Presentation: 80mg/4ml, €167.53; 200mg/10ml, €418.82; 400mg/20ml, €837.65. Indications: In combination with methotrexate (MTX), for the treatment of... Read more
Venlift
01 May 2009 | New Products
Company: Ranbaxy UK. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Venlafaxine 37.5mg, 75mg. (eq. to 42.413mg venlafaxine HCl). Description: Peach coloured, mottled, uncoated, shield-shaped tablets debossed with V and 2 or V and 4, respectively, on one side and... Read more
Gaviscon Advance Oral Suspension Sachets
01 May 2009 | New Presentations
Company: Reckitt Benckiser. Legal category: OTC. Sport permitted. Active ingredient: Sodium alginate 100mg, potassium hydrogen carbonate 20mg per 1ml. Description: Off-white viscous suspension in sachets. Presentation: 10ml-20, €5.30. Indications: Symptoms of gastro-oesophageal reflux such as acid regurgitation, heartburn and indigestion... Read more
